GlassScriptHydropicc Dual Lumen
Payments companies reported to CMS as associated with Hydropicc Dual Lumen. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hydropicc Dual Lumen, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hydropicc Dual Lumen
These are the largest totals companies reported as associated with Hydropicc Dual Lumen. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Michael Jaff | Boston, MA | Internal Medicine | $13,686.06 |
| David Longworth | Burlington, MA | Internal Medicine | $7,794.93 |
| Gary Ansel | Columbus, OH | Interventional Cardiology | $5,442.85 |
| Marcia Ryder | Syracuse, NY | Nurse Practitioner | $3,285.47 |
| Brian Jankowitz | Philadelphia, PA | Neurological Surgery | $2,887.50 |
| Matthew Ostroff | Paterson, NJ | Acute Care (Nurse Practitioner) | $2,696.49 |
| Michael Mccurdy | Towson, MD | Emergency Medicine | $1,051.88 |
| Arun Jagannathan | Kankakee, IL | Vascular & Interventional Radiology | $875.00 |
| Gail Egan | Sacramento, CA | Nurse Practitioner | $639.25 |
| Patrick Evangelista | Irvine, CA | Acute Care (Nurse Practitioner) | $346.30 |
Prescribed Hydropicc Dual Lumen?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.